Syntara Limited

DB:UUDA Stock Report

Market Cap: €75.0m

Syntara Management

Management criteria checks 3/4

Syntara's CEO is Gary Phillips, appointed in Mar 2013, has a tenure of 11.83 years. total yearly compensation is A$830.67K, comprised of 56.7% salary and 43.3% bonuses, including company stock and options. directly owns 0.36% of the company’s shares, worth €270.63K. The average tenure of the management team and the board of directors is 4.9 years and 4.8 years respectively.

Key information

Gary Phillips

Chief executive officer

AU$830.7k

Total compensation

CEO salary percentage56.7%
CEO tenure11.8yrs
CEO ownership0.4%
Management average tenure4.9yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gary Phillips's remuneration changed compared to Syntara's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$831kAU$471k

-AU$14m

Mar 31 2024n/an/a

-AU$10m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$18m

Jun 30 2023AU$754kAU$462k

-AU$13m

Mar 31 2023n/an/a

AU$2m

Dec 31 2022n/an/a

-AU$2m

Sep 30 2022n/an/a

AU$2m

Jun 30 2022AU$628kAU$451k

-AU$2m

Mar 31 2022n/an/a

-AU$16m

Dec 31 2021n/an/a

-AU$12m

Sep 30 2021n/an/a

-AU$1m

Jun 30 2021AU$683kAU$444k

-AU$3m

Mar 31 2021n/an/a

AU$5m

Dec 31 2020n/an/a

-AU$4m

Sep 30 2020n/an/a

-AU$13m

Jun 30 2020AU$559kAU$440k

-AU$14m

Mar 31 2020n/an/a

-AU$21m

Dec 31 2019n/an/a

-AU$18m

Sep 30 2019n/an/a

-AU$18m

Jun 30 2019AU$613kAU$433k

-AU$20m

Mar 31 2019n/an/a

-AU$27m

Dec 31 2018n/an/a

-AU$12m

Sep 30 2018n/an/a

-AU$22m

Jun 30 2018AU$776kAU$424k

AU$6m

Compensation vs Market: Gary's total compensation ($USD518.59K) is about average for companies of similar size in the German market ($USD462.70K).

Compensation vs Earnings: Gary's compensation has increased whilst the company is unprofitable.

CEO

Gary Phillips (63 yo)

11.8yrs

Tenure

AU$830,674

Compensation

Mr. Gary Jonathan Phillips, BPharm, MBA, serves as Independent Non-Executive Director at Arovella Therapeutics Limited since July 1, 2022. He has been Chief Executive Officer and Managing Director of Synta...

Leadership Team

NamePositionTenureCompensationOwnership
Gary Phillips
CEO, MD & Director11.8yrsAU$830.67k0.36%
€ 270.6k
Wolfgang Jarolimek
Head of Drug Discovery12.4yrsAU$533.03k0.11%
€ 81.7k
Kristen Morgan
Head of Medical & Regulatory Affairs - Alliance Managementno dataAU$360.60k0.021%
€ 15.5k
Jana Baskar
Chief Medical Officer2.5yrsAU$455.75k0.097%
€ 72.9k
David McGarvey
Company Secretaryless than a yearAU$603.03k0.066%
€ 49.4k
Timothy Luscombe
Chief Financial Officerless than a yearno datano data
Cameron Billingsley
General Counselno datano datano data
Dieter Hamprecht
Head of Chemistry7.3yrsno datano data

4.9yrs

Average Tenure

60yo

Average Age

Experienced Management: UUDA's management team is considered experienced (4.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gary Phillips
CEO, MD & Director11.8yrsAU$830.67k0.36%
€ 270.6k
Simon Green
Independent Non-Executive Director2.1yrsAU$73.63k0.058%
€ 43.2k
Kathleen M. Metters
Independent Non Executive Chair7.6yrsAU$112.80k0.0013%
€ 952.2
Waradana Malitha De Silva
Non-Executive Director2yrsAU$73.63k0.020%
€ 15.1k

4.8yrs

Average Tenure

Experienced Board: UUDA's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 07:28
End of Day Share Price 2025/01/06 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Syntara Limited is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Anubhav SaxenaBell Potter
Thomas WakimBell Potter